August 25, 2023
Antifungal-resistant Ringworm Infections
Ringworm, also called tinea or dermatophytosis, is a common fungal infection of the hair, skin, or nails caused by dermatophyte fungi. Ringworm spreads easily by skin-to-skin contact with infected animals or people and by fomites (everyday objects or surfaces that may be contaminated). Usually, ringworm skin infections are minor ailments that can be treated successfully with topical antifungal medications or oral terbinafine, a first-line oral antifungal drug for ringworm, in cases of widespread infection.
However, ringworm caused by Trichophyton indotineae, a frequently antifungal-resistant fungus, can cause widespread, highly inflamed lesions on the face, trunks, arms, legs, or groin. Trichophyton indotineae infections generally do not improve when treated with most topical antifungals or terbinafine. Antifungal-resistant ringworm is difficult to treat and can affect anyone, including people with healthy immune systems. Outbreaks of antifungal-resistant ringworm are occurring in the Indian Subcontinent, and cases have been detected throughout Asia and Europe.
Dermatologists and public health officials in New York City have reported cases of severe ringworm caused by Trichophyton indotineae and fungal nail infections resistant to terbinafine. In July 2023, an analysis from a reference laboratory testing dermatophyte isolates from several U.S. states and Canada found that 19% of the isolates were resistant to terbinafine. A study from France described severe ringworm cases potentially transmitted during sex among men who have sex with men. To date, there have been no similar published reports of ringworm transmitted through sexual contact in the United States. Additional data are needed to understand the extent of severe and antifungal-resistant ringworm in the United States.
Recommendations for Clinicians
The Emergency Risk Communication Branch in the Division of Emergency Operations, Office of Readiness and Response is responsible for the management of all COCA Products.
For information about this update or other clinical issues, or to send your feedback, please contact us at firstname.lastname@example.org
Clinician Outreach and Communication Activity—resources for healthcare providers
COCA RSS Feed—subscribe to be notified of conference calls, updates, and CDC guidance for health providers
Crisis & Emergency Risk Communication Training—training program that draws from lessons learned during public health emergencies, and incorporates best practices from the fields of risk and crisis communication
Health Alert Network—CDC's primary method of sharing cleared information about urgent public health incidents with public information officers; federal, state, territorial, and local public health practitioners; clinicians; and public health laboratories
CDC and HHS logos are the exclusive property of the Department of Health and Human Services and may not be used for any purpose without prior express written permission. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
Links to non-federal organizations are provided solely as a service to our users. Links do not constitute an endorsement of any organization by CDC or the federal government, and none should be inferred. CDC is not responsible for the content of the individual organizations.